180 Life Sciences Corp.
ATNF
$1.82
-$0.0099-0.54%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.98M | 2.66M | 2.01M | 2.65M | 6.97M |
| Total Receivables | 450.10K | 130.40K | 89.50K | 357.50K | 621.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.21M | 578.00K | 836.30K | 1.19M | 1.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.64M | 3.37M | 2.93M | 4.20M | 8.93M |
|
|
|||||
| Total Current Assets | 3.64M | 3.37M | 2.93M | 4.20M | 8.93M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.62M | 1.59M | 1.67M | 1.66M | 1.66M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 9.06M | 9.06M | 9.06M |
| Total Assets | 5.26M | 4.96M | 13.67M | 14.92M | 19.65M |
|
|
|||||
| Total Accounts Payable | 2.16M | 1.76M | 890.20K | 1.21M | 1.80M |
| Total Accrued Expenses | 1.82M | 2.65M | 2.72M | 2.29M | 2.35M |
| Short-term Debt | 1.02M | -- | -- | -- | 1.30M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.90K | 332.90K | 588.20K | 842.20K | 11.90K |
| Total Finance Division Other Current Liabilities | 50.10K | 55.60K | 75.80K | 786.60K | 200.60K |
| Total Other Current Liabilities | 50.10K | 55.60K | 75.80K | 786.60K | 200.60K |
| Total Current Liabilities | 5.06M | 4.81M | 4.27M | 5.12M | 5.66M |
|
|
|||||
| Total Current Liabilities | 5.06M | 4.81M | 4.27M | 5.12M | 5.66M |
| Long-Term Debt | 19.90K | 22.20K | 26.30K | 28.70K | 31.20K |
| Short-term Debt | 1.02M | -- | -- | -- | 1.30M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 304.70K | 278.40K | 2.65M | 2.63M | 2.62M |
| Total Liabilities | 5.39M | 5.11M | 6.95M | 7.78M | 8.31M |
|
|
|||||
| Common Stock & APIC | 130.12M | 128.82M | 125.47M | 122.20M | 121.64M |
| Retained Earnings | -127.34M | -126.12M | -115.85M | -112.17M | -107.41M |
| Treasury Stock & Other | -2.90M | -2.85M | -2.90M | -2.88M | -2.89M |
| Total Common Equity | -127.70K | -149.30K | 6.72M | 7.14M | 11.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -127.70K | -149.30K | 6.72M | 7.14M | 11.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -127.70K | -149.30K | 6.72M | 7.14M | 11.34M |
|
|
|||||
